Welcome To The Mannkind HUB On AGORACOM
Edit this title from the Fast Facts Section
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

BREAKING NEWS!!!

Virtutone Announces Earnings of $0.02 per share for period ended July 31, 2014

  • Virtutone net revenues reached $43,216,403 for the second quarter of 2014, an increase of $34,555,976 or 399 % compared to the same period a year earlier, and an increase of $14,853,436 or 52 % compared to the first quarter of 2014

Hub On AGORACOM / Read Release

 

Message: 2 Things to Watch at MannKind Corporation

Swing
Rank: [?]
Vice President
Points: [?]
1424
Rating: [?]
Votes: 10 Score: 4.2
  • Currently 4.2/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Re: 2 Things to Watch at MannKind Corporation

posted on Jan 30, 13 08:14AM

Aside from not proof reading the copy the logic seems flawed in this statement:

"Given his knowledge of this industry -- and the many lessons learned from Exubera's failure -- Dance's product could be an improved, next-generation insulin that might better serve the needs of diabetes patients. Its product is still in early development, but this is (a) something investors should keep an eye on."

Just because somebody was associated with a screw up doesn't mean they learn from the mistake. That would be like naming our current president to be the Fed chairman after racking up 8 years of trillion dollar deficits.

This article seems more like FUD for MNKD and pumping Dance to me. Why would Dance be more capable of bringing an inhaled insulin to market if as is indiacted earlier in the article it is unclear whether or not inhaled insulin will be embraced by the market? Absolutely nothing is said regarding the efficacy, safety or benefits of Afrezza.

Swing

New Message

Please login to post a reply

AGORACOM Quick Tips

What Is Twitter? Watch Our 5-Minute Tutorial ... Watch Now

President's D.D.

Here's the latest Griffin report read more

Stock Quote

Hub Leaders